Affect Therapeutics
Series BSep 2025

Series B — Affect Therapeutics

$26.0MRaised

Overview

Funding Type

Series B

Additional funding details

Free accounts get 25 credits every month. A funding reveal uses credits.

About Affect Therapeutics

Healthcare

McLean, United States

View Full Profile